Oral combination chemotherapy of 5'-deoxy-5-fluorouridine (furtulon) and cyclophosphamide for advanced breast cancer / 中华肿瘤杂志
Chinese Journal of Oncology
; (12): 282-284, 2003.
Article
em Zh
| WPRIM
| ID: wpr-347441
Biblioteca responsável:
WPRO
ABSTRACT
<p><b>OBJECTIVE</b>To evaluate the efficacy and safety of the oral combination chemotherapy of furtulon (FTL) and cyclophosphamide (CTX) for advanced breast cancer (ABC).</p><p><b>METHODS</b>From Jun 2000 to Jun 2002, eighty-three patients with ABC were treated with the two oral drugs as combined chemotherapy. The mean number of cycles was 5, median number of cycles was 6 (range 2-6).</p><p><b>RESULTS</b>The overall response rate was 45.8%, The median time to progression was 6 months. The treatment was well tolerated, with related Grade 3 clinical adverse effect being only nausea and vomiting in 2 patients (2.4%) and mild hematologic toxicities.</p><p><b>CONCLUSION</b>Oral combined chemotherapy of FTL and CTX, being convenient and safe, is effective for patients with advanced breast cancer.</p>
Texto completo:
1
Base de dados:
WPRIM
Assunto principal:
Neoplasias da Mama
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Administração Oral
/
Floxuridina
/
Ciclofosfamida
/
Usos Terapêuticos
/
Tratamento Farmacológico
Limite:
Adult
/
Aged
/
Female
/
Humans
Idioma:
Zh
Revista:
Chinese Journal of Oncology
Ano de publicação:
2003
Tipo de documento:
Article